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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose(s): Approximately 40% of patients with profound T-cell immunodeficiency
have no identified molecular basis. Early assessment of T-cell impairment is vital for medical
intervention, if hematopoietic stem cell transplantation is needed. The dynamics of T-cell
receptor excision circles (TRECs) revealing recent thymic output of naı¨ve T cell and T-cell
receptor (TCR) repertoire diversity reflecting broader responses to multiple antigens, are both
important in resisting infections.
Methods: The TRECs value and TCR repertoire diversity were evaluated from peripheral blood
mononuclear cells in patients with primary severe T cell immunodeficiency, to elucidate the T-
cell response.
Results: In seven children with <30% of normal phytohemagglutinin (PHA)-stimulated lympho-
cyte proliferation, including two IL2RG (Try74Gly and Arg226Lys, X-linked) and one RAG2 muta-
tions [(Ser205Tyr) and (del 1366T, frameshift, 484stop); autosomal recessive], lower TRECsmunodeficiency Care and Research (PICAR) Institute, Chang Gung Memory Hospital and University,
er 5 Fu-Shing Street (Pediatric Office 12 L), Kwei-Shan, Taoyuan, Taiwan.
.com (W.-I. Lee).
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TRECs and TCR repertoire in profound T-cell deficiency 375value and oligo- and restricted TCR diversity patterns, were associated with increased suscep-
tibility to opportunistic infections, but not inversely correlated to the severity and frequency
of infections. Three patients had successful cord blood stem cell transplantation which recon-
structed the T cell immunodeficiency, with normalized TRECs value and TCR repertoire diver-
sity at 6 months post-transplant, without clinical events.
Conclusion: Low TRECs value and restricted TCR repertoire diversity can help in the early
diagnosis of T cell immunodeficiency before irreversible sequelae and in the monitoring of
post-transplantation T-cell immune reconstruction.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Primary immunodeficiency diseases (PIDs) are natural
knockout human models for investigating complex immune
mechanisms of increased susceptibility to infections.1,2
Identified genetic defects elucidate causal molecules in
the host immunity’s fight against pathogens. To date, at
least 206 kinds of PIDs have been recognized and almost 110
genetic defects explored.3 The clinical manifestations of
PIDs with identified genetic defects are more predictable,
because a relationship between genotype and phenotype
exists despite rare exceptions.4e6 In cases still without
identified genetic defects, immune functional analysis has
become more important and practical for aggressive
intervention, like hematopoietic stem cell transplantation
(HSCT), which is mandatory for rescuing PIDs with severe T
and phagocytic disorders.7e11 In patients with profound T-
cell immunodeficiency of <30% mitogen [e.g., phytohe-
magglutinin (PHA)] proliferation function in healthy indi-
viduals,12 often presenting as severe combined T and B
immunodeficiency (SCID)], >95% of SCID patients have
successful HSCT and excellent prognosis if diagnosed and
transplanted before the age of 3 months.9,13
Patients with profound T-cell immunodeficiency and
identified genetic defects are candidates for pre-natal
diagnosis for early HSCT of the children if parents are
carriers. However, in profound T-cell immunodeficiency
like SCID, approximately 40% of patients (858/2157)
remained without identified genetic defects, even after the
end of the human genome projects in 2000.14 Sporadic and/
or de novo mutation cases are diagnosed only after severe
and/or opportunistic infections and irreversible sequelae.
Despite HSCT for such situations, the success rate of
engraftment is reduced to <75% and the life quality is not
as well tolerated.11,13 To predict the phenotypic severity of
profound T-cell immunodeficiency for early HSCT if indi-
cated, T-cell receptor excision circles (TRECs) and T-cell
receptor (TCR) repertoire are used to investigate T-cell
production, development, and maturation if with severe
and/or refractory infections before 3 months of age.
The majority of T cells generated in the thymus express
TCR composed of alpha-(A) and beta-(B) chains, which are
encoded by variable (V), diversity (D), and junctional (J)
gene segments rearranged to form the highly diverse hyper-
variable TCR regions during the process of V(D)J recombi-
nation. These regions are largely responsible for the
antigenic specificity of the individual TCR and are called
“TCR repertoire”.15 Rearrangement of both the TCRA andTCRB genes during T-cell maturation produces TRECs,
formed when the intervening stretches of DNA are excised
as the “coding” ends which are joined to form a functional
TCR gene in chromosomal DNA.15,16 Such TRECs can be
used to detect and quantify thymic output of alpha-beta
(ab)-T cells.17
Like conventional lymphocyte proliferation function to
evaluate T cell immunity, TRECs and TCR repertoire in this
study were used to qualify T-cell function and elucidate the
relationship between phenotype and these functions on
patients with profound T-cell immunodeficiency, but
unknown genetic defects.
Materials and methods
Patients
The Human Investigation Committee approved this study
and the participant’s parents or guardians provided
informed consent. Excluding those with malignancy, zinc
deficiency, malnutrition, and human immunodeficiency
virus (HIV) infection, patients with profound primary T-cell
immunodeficiency characterized by lymphopenia, chronic
diarrhea, failure to thrive, and/or opportunistic infections,
with <30% normal PHA-stimulated proliferation function
were enrolled.12,18
Heparinized venous blood samples (10e15 mL) from
patients and healthy controls were sent to the laboratory
within 72 hours. Serum immunoglobulins and lymphocyte
subsets, including T-, B-, and NK-cells, activated lympho-
cytes, and memory cells were evaluated. Candidate genes
were further sequenced as in a previous study.19
Lymphocyte proliferation function
To induce lymphocyte proliferation, peripheral blood
mononuclear cells (PBMCs; 105/well) were incubated
in vitro with concentrations of PHA, concanavalin A (ConA),
and pokeweed mitogen (PWM) for 3 days, or the Candida
antigen and BCG vaccine for 7 days. Stimulation was then
incubated with 3H-thymidine as previously described.20
T-cell receptor excision circles (TRECs) analysis
Real-time quantitative polymerase chain reaction (PCR) for
detecting TRECs and b-actin was performed in a total
volume of 20 mL containing 1X TaqMan Gene Expression
Figure 1. Real-time PCR amplification demonstrated a linear
relationship between detectable PCR cycle number (Ct; Y axis)
and serial log dilution of TREC copy number (X axis).
376 M.-Y. Hsieh et al.Master Mix (Applied Biosystems, Foster city, CA, USA),
0.5 mmol/L TREC primers, 0.25 mmol/L b-actin primers,
0.15 mmol/L TaqMan probes, and 0.8 mL 1% BSA (New
England Biolabs, Ipswich, MA, USA). The DNA sequences of
the primers and probes are listed in Table 1. The reactions
were carried out on an ABI 7900HT Fast Real-Time PCR
System (Applied Biosystems), with one cycle at 5C for 2
minutes, one cycle at 95C for 5 minutes, and 40 cycles at
95C for 30 seconds and at 60C for 60 seconds.
For data collection, a fixed cycle threshold (Ct) was set
at the point when PCR amplification was still in the expo-
nential phase. The Ct was the number of cycles at which
the amplification plot, representing the fluorescence
emission of the report dye, passed a fixed threshold. Seri-
ally diluted plasmids containing a known copy number of
TRECs and b-actin were used to generate a calibration
curve. The copy numbers of TRECs and b-actin were auto-
matically determined based on this curve (a representative
TRECs standard curve is demonstrated in Fig. 1). The PCR
amplification of the b-actin gene was used as a reference
gene to assess successful DNA extraction. The b-actin and
Ca gene primers were also designed to generate amplicons
flanking an intron/exon junction.Table 1 Sequence of primers used for TREC and TCR repertoire
TRECs Forward (50-30 sequence)
TRECs CCA TGC TGA CAC CTC TGG TT
b-actin ATT TCC CTC TCA GGC ATG GA
Ca: CCT GAT CCT CTT GTC CCA CAG
TREC probe 6FAM-CAC GGT GAT GCA TAG G
CCT GC-TAMRA
b-actin probe 6FAM-GTG GCA TCC ACG AAA CT
Ca: probe 6FAM-GTG GCA TCC ACG AAA CT
TCR repertoire
VB1 GCACAACAGTTCCCTGACTTGCAC
VB2 TCATCAACCATGCAAGCCTGACCT
VB3 GTCTCTAGAGAGAAGAAGGAGCG
VB4 ACATATGAGAGTGGATTTGTCATT
VB5.1 ATACTTCAGTGAGACACAGAGAAA
VB6.1 AGGCCTGAGGGATCCGTCTC
VB7 CCTGAATGCCCCAACAGCTCTC
VB8 ATTTACTTTAACAACAACGTTCCG
VB9 CCTAAATCTCCAGACAAAGCTCAC
VB10 CTCCAAAAACTCATCCTGTACCTT
VB11 TCAACAGTCTCCAGAATAAGGACG
VB12 AAAGGAGAAGTCTCAGAT
VB13.1 CAAGGAGAAGTCCCCAAT
VB14 GTCTCTCGAAAAGAGAAGAGGAA
VB15 AGTGTCTCTCGACAGGCACAGGC
VB16 AAAGAGTCTAAACAGGATGAGTCC
VB17 CAGATAGTAAATGACTTTCAG
VB18 GATGAGTCAGGAATGCCAAAGGA
VB19 CAATGCCCCAAGAACGCACCCTGC
VB20 AGCTCTGAGGTGCCCCAGAATCTC
3’CB TTCTGATGGCTCAAACACT-cell receptor (TCR) repertoire size (CDR3)
spectra-typing
Total RNA was prepared from CD4þ T cells after sorting as
described.21 Total RNA (2 ug) was synthesized as cDNA usingspectra-typing
Backward (50-30 sequence)
TCG TGA GAA CGG TGA ATG AAG
CGT CAC ACT TCA TGA TGG AGT TG
GGA TTT AGA GTC TCT CAG CTG GTA CA
CA
A-TAMRA
A-TAMRA
C
C
T
T
A
Table 2 Immunologic functions and clinical manifestations of patients with profound T-cell immunodeficiency on diagnosis
P1 P2 P3 P4 P5 P6 P7 Normal range
Sex/age at
diagnosis
M/3M M/4M F/7M M/17M M/5M M/5M F/4M (n Z 7c)
Genetic defects Unidentified Unidentified Unidentified Unidentified IL2RG (Trp74Gly) IL2RG (Arg226Lys) RAG2
(heterozygous)b
Lymphocyte
(/mm3)
604 5700 295 114 297 7506 474 2500e5600
Immunoglobulin (mg/dL, IU/ml)
IgG 124 231 146 1210a 245 99 83 294e1069
IgA 23 <6 <6 168 30 <6 <6 16e84
IgM 12 <4 <4 273 31 21 <4 41e149
IgE <19 <19 <19 <19 <19 <19 <19
Lymphocyte subsets (%)
CD4 23 21 3 34 2 1 1 35e64
CD8 15 19 2 23 3 20 1 12e28
CD19 18 54 12 32 76 74 2 6e41
NK 47 15 54 8 2 2 92 3e18
CD4þ memory 16 16 2 11 2 0 0 2e22
CD19þ memory 2 2 15 0 2 0 0 1.4e6.6
Activated
lymphocyte
3 7 2 39 16 31 19 4e26
Lymphocyte proliferation [c.p.m. for amitogens (PHA, ConA and PWM) and antigens (Candida and BCG)]
PHA 10 mg/mL 3124 4235 2457 7498 4264 6547 3573 83,042e201,534
ConA 10 mg/mL NA 2159 1897 3197 2716 4465 3198 41,326e85,507
PWM 0.1 mg/mL NA NA NA 6381 1507 3123 2493 23,179e42,397
Candida
10 mg/mL
2348 1283 598 5465 1294 191 346 8457e24,269
BCG 0.25 mg/mL NA NA 477 2523 349 196 453 4267e14,738
Infections Chronic diarrhea
Pneumonia
CMV encephalitis
Epilepsy
Pneumonia
Salmonella sepsis
Bronchiectasis
Influenza
pneumonia
BCGitis
Candidiasis
Pneumonia
Bronchiectasis
ORSA cellulites
Chronic diarrhea
BCGitis
Pneumocystis
jiroveci
pneumonia
Bronchiectasis
E. coli sepsis
Pseudomonas
sepsis
BCGitis
Pneumocystis
jiroveci pneumonia
Candidiasis
Pneumocystis
jiroveci pneumonia
Bronchiectasis
HSCT (source) No No No Yes (cord blood) Yes (cord blood) Yes (cord blood) Yes (bone marrow)
Prognosis
(mortality cause)
Mortality at 5 mo
(respiratory failure)
Mortality at 6 mo
(respiratory failure)
Mortality at 8 mo
(respiratory failure)
Alive Alive Alive Mortality at 8 mo
(pneumothorax)
a After regular monthly IVIG infusion.
b Paternal allele with missense mutation Ser 205 Tyr and maternal allele with deletion mutation 1366 T, frameshift, stop at the 484.
c Normal range was obtained from 7 age-matched healthy controls receiving regular vaccination.
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378 M.-Y. Hsieh et al.reverse transcriptase (Invitrogen. Each cDNA sample was
amplified using a V beta-specific primer with a C-3’ primer
(Table 1) at a final concentration of 0.3 uM in each reaction.
In a 1:3 dilution of fluorescent PCR products, 3 uL were
combined with an equal amount of formamide dye and heat
denatured at 90C for 3 minutes. Applied Biosystems Gen-
eScan Software (Foster City, CA, USA) was used for the
collection and analysis of the fluorescent-labeled PCR
products. A fluorescent size marker was employed to
determine the length of each band.
For evaluation of fluorescent spectra-types, histograms
were generated from data collected either by an ABI/DNA
Sequencer or a Molecular Dynamics FluorImager. Using
a labeled TCR BC region primer and TCR BV-specific
primers, both band number and intensity were examined.
The overall intensity of the bands was a function of the
cycle number and the starting concentration of cDNA.
The peaks’ patterns were defined by lightly changing the
previous definitions.21 A CDR3 fragment profile with 5e9
peaks/vb families and a Gaussian (bell shaped) distribution
was called the “polyclonal” pattern. Oligoclonal profile
resulted in a pattern of no more than four peaks per vb
family, while the presence of a peak with an area >50% of
the total area for that family was defined as restricted or
skewed.Results
Patient characteristics
In the period 2005e2008, there were seven enrolled
patients, including two females, with profound T cell
immunodeficiency and <30% of the normal lymphocyte
proliferation to the mitogen PHA12,18 who presented as
interstitial cytomegalovirus or Pneumocystis jiroveci
pneumonia (P2, P5, P6, and P7), oral candidiasis (P4 and
P7), or failure to thrive and/or chronic diarrhea (P1 and P4)
(Table 2). Decreased IgG level was all below the normalTable 3 T-cell receptor excision circles (TRECs) in patients wit
P1 P2 P3 P4
At diagnosis 3M 4M 7M 17M
Genetic defects Unidentified Unidentified Unidentified Unide
GvHDa Grad
TRECs copy number/106 PBMCs
Before
transplantation
3.03  103 1.44  105 4.84  104 2.92
Post-transplant
6 mo
NA NA NA 8.25
TRECs / Ca
Pre-transplant 6.07  106 7.94  105 3.41  105 5.53
Post-transplant
6 mo
NA NA NA 1.28
a Prophylactic GvHD contained cyclosporine and methylprednisolone
(ATG) 15 mg/kg twice daily, i.v. for 4 consecutive days (Day -4 to Da
NA Z not available.range except in P4, who had normal immunoglobulins but
obvious lymphopenia and hepatosplenomegaly.
Two missense mutations of IL2RG (Try74Gly and Arg
226Lys, X-linked) and one complex mutation of RAG2
(missense mutation Ser 205 Tyr and deletion mutation 1366
T, frameshift, stop at the 484; autosomal recessive) were
identified. Three patients (P1, P2, and P3) developed
severe and refractory pneumonia after their first admission
and died of respiratory failure before transplantation. Four
patients had successful HSCT but P7 developed Grade III
graft-versus-host disease (GVHD) and died of pneumothorax
secondary to multiple bronchopleural fistulas.
T-cell receptor excision circles (TRECs) evaluation
Two evaluation systems of absolute and relative quantity of
TRECs were utilized. For absolute quantity, a standard T&A
cloning plasmid with one PCR product of TRECs was con-
structed and transfected into XL-1 blue DH-5a component
cells. Direct sequencing demonstrated that the inserted
DNA had no mutation and each insert was present in
a single copy. Small aliquots of standard dilutions con-
taining 106 to 102 copies of this vector were stored at
e80C. Seven age-matched healthy children were enrolled
as controls. The detectable TRECs ranged from 3.03  103
to 1.44  105 fewer than controls (2.48  105 to 8.53  106)
based on 106 PBMCs (Table 3). For relative quantity,
consistent Ca chain was used as an internal control for each
individual. Similar patterns of lower expression ratio were
detected (6.07  106 to 2.43  105 in patients versus
1.92  104 to 1.17  102 in controls). Normalized TRECs
were obtained in three patients after 6 months post-
transplantation.
TCR (CDR3) size spectra-typing analysis
Healthy controls had polyclonal patterns with Gaussian (bell
shaped) distribution in Vb TCR repertoire (Fig. 2A). All sevenh profound T-cell immunodeficiency
P5 P6 P7 Normal range
(n Z 7)
5M 5M 4M
ntified IL2RG IL2RG RAG2
e II Grade I Grade I Grade III
 104 5.24  104 6.88  104 6.01  104 2.48  105
e8.53  106
 106 8.04  106 9.85  105 NA
 105 2.43  105 3.12  105 4.00  105 1.92  104
e1.17  102 104 1.64  102 5.64  103 NA
and pre-condition medications, including anti-thymocyte globulin
y -1).
Figure 2. (A) Polyclonal TCR repertoire was detected in healthy controls; (B) oligo- and skewed TCR repertoire was present in
patients with profound T-cell immunodeficiency, represented by patient P5; (C) these were reconstructed after umbilical cord
stem cell transplantation.
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representative demonstration in Fig. 2B). After successful
transplantation, donor progenitor hematopoietic stem cells
developed into effective T cells with polyclonal TCR reper-
toire patterns (Fig. 2C).Discussion
TRECs were first reported in 1988 by Douek et al16 to study
changes in the frequency of recent thymic emigrants with
age and in the case of HIV infection. T cell receptor gene
rearrangements occur in maturing thymocytes and TRECs
are subsequently detected in thymocytes and in mature T
cells.16,22e24 For profound T-cell defective function deter-
mined using neonatal Guthrie cards, TRECs evaluation is
useful in recognizing patients with DiGeorge syndrome,
idiopathic T-cell lymphopenia, SCID with IL2RG, JAK3, ADA,
LIG4 and Rac mutation, and secondary disorders of
lymphocyte extravasation, including chylothorax, chylo-
peritoneum and gastroschisis in Wisconsin, California,
Massachusetts, and Japan2,25e27
Instead of Newborn screening in Guthrie cards (NBS) with
whole blood, lymphocytes were directly utilized to count
recent thymic emigrants. Leaky (in P1, P2, and P4) or
maternal (in P6) T cells mainly presented as residual trans-
placental memory cells, with obviously decreased TRECs.
Patients with TRECs below the normal range had higher
infectious susceptibility to opportunistic pathogens (i.e.,
BCGitis, CMV, Pneumocystis jiroveci pneumonia, and
Candida), compatible to T cell defects. However, the
relationship of the TRECs value to the severity and
frequency of infection was not inversely correlated, which
might be ascribed to environmental hygiene and
surrounding pathogens.
“TCR repertoires” are rearranged to form highly diverse
hyper-variable regions of TCR during the process of V(D)J
recombination and are responsible for the antigenic speci-
ficity of the individual TCR.15 Polyclonal distribution is
detected in infant healthy controls at 3 months of age,
showing capability for a broader reactivity to multiple
antigens. In contrast, patients of the same age, but with
severe defective T cells, only reveal oligo- or/and
restricted TCR repertoires caused by disturbed V(D)J
recombination and hyper-somatic mutation. In line with
TRECs, patients with defective T cell functions who have
oligo- or restricted TCR repertoires have increasing oppor-
tunistic infections with increasing age. Oligo- or restricted
patterns of a TCR repertoire seem to be related to the
expression of residual trans-placental maternal T memory
or leaky cells (in P1, P2, P4, and P6).28e30
Successful umbilical cord blood stem cell trans-
plantation reconstructed T cell immunity after 6 months
in this series. Immuno-reconstitution after HSCT report-
edly depends on two different pathways.31e33 The first
wave consists of thymic-independent graft-derived
mature donor T cells to the periphery, followed by antigen
or cytokine expansion. The resulting circulating T cells
have limited T-cell repertoire diversity and are unable to
respond to a broad range of pathogens.34,35 The second
wave is a thymic-dependent pathway that involves the
selection of graft-derived precursor cells in the host’sthymus and/or possibly in the periphery.36e40 This process
accounts for a more durable reconstitution of the T-cell
compartment, with a more diverse T-cell repertoire. The
first wave is mainly from mature memory cells and may
cause GVHD. In patients with GVHD and infectious
complications, increased effective mature T-cell prolif-
eration may dilute the recent thymic emigrants and
consequently decrease the TRECs value.17 Umbilical cord
blood stem cell transplantation, with no or fewer donor’s
maternal transplant memory cells, attenuates the severity
of GVHD in the first wave (P4, P5 and P6 vs. P7) and
rapidly promotes the second wave for TCR repertoire
diversity in the thymus and periphery at 6 months post-
transplantation.
Pre-natal genetic diagnosis for PIDs with family history
and identified genetic mutation allows for early interven-
tion and prevention of irreversible sequelae. To those
patients with profound defective T cells, with de novo
mutation and unidentified molecular basis, lower TRECs
and restricted TCR repertoire compatible with severe
impaired PHA-stimulated lymphocyte proliferation and
phenotypic severity in the period of infancy are authentic
ways for early recognition and treatment, even HSCT under
infection-free conditions. However, the frequency and
severity of infections are not inversely correlated to lower
TRECs value and restricted TCR repertoire diversity in this
series.
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